Iontronic Pumps: A Novel Tool for Targeted Brain Tumor Treatment
Verena Handl a, Linda Waldherr a, Sabine Erschen a, Astrid Gorischek a, Joachim Distl a, Rainer Schindl a, Theresia Arbring Sjöström b, Tobias Abrahamsson b, Maria Seitanidou b, Magnus Berggren b, Tamara Tomin c, Sophie Honeder c, Ruth Birner-Grünberger c, Waltraud Huber d, Nassim Ghaffari-Trabizi-Wizsy d, Martin Asslaber e, Marta Nowakowska f, Ute Schäfer f, Silke Patz f, Daniel Simon b, Muammer Ücal f
a Gottfried Schatz Research Center – Biophysics, Medical University of Graz, 8010 Graz, Austria
b Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, 60174 Norrköping, Sweden
c Institute of Chemical Technologies and Analytics, Technische Universität Wien, 1060 Vienna, Austria
d Otto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, 8010 Graz, Austria
e 6Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria
f Research Unit of Experimental Neurotraumatology, Medical University of Graz, 8036 Graz, Austria
Materials for Sustainable Development Conference (MATSUS)
Proceedings of MATSUS Fall 2023 Conference (MATSUSFall23)
#BIOEL - Bioelectronics
Torremolinos, Spain, 2023 October 16th - 20th
Organizers: Francesca Santoro and Achilleas Savva
Poster, Verena Handl, 332
Publication date: 18th July 2023

Local administration of potent chemotherapeutic agents holds significant promise as a therapeutic strategy to enhance the effectiveness of treating challenging tumors, particularly glioblastoma multiforme (GBM), one of the most deadly brain tumors. Despite their strong anti-GBM properties, chemotherapeutics like Gemcitabine (Gem) face limitations due to their inefficient passage through the blood-brain barrier.

In this study, we present an innovative approach using freestanding iontronic pumps, referred to as GemIPs, containing a specially synthesized ion exchange membrane, to deliver Gem locally in a GBM model situated on the chicken chorioallantoic membrane. In parallel, we compare the outcomes with a conventional daily topical treatment regimen. Our findings reveal that both administration methods induce G2-phase cell cycle arrest and apoptosis in GBM cells.

Notably, we observed significant growth inhibition exclusively with the sustained Gem dosage via GemIPs, whereas daily topical drug administration at maximum safe doses did not result in lethality for the chick embryo but failed to inhibit tumor growth. We postulate that the dissimilar transient concentration profiles generated by these techniques underlie this distinction in outcomes. To support this hypothesis, we developed a digital model of the experiment, which predicts rapid concentration decay with daily topical treatment but sustained high local Gem concentrations near the tumor site with GemIPs.

The application of continuous chemotherapy through iontronic devices introduces a novel dimension to cancer treatment. It enables prolonged and highly localized delivery of clinically available potent chemotherapeutic agents, offering the potential to significantly enhance treatment efficacy while minimizing systemic side effects. In summary, our study underscores the promising prospects of this approach, particularly when considering its application in the context of rat animal experiments.

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info